NO20080059L - Indol-3-karbonyl-spiro-piperidinderivater som V1A-reseptorantagonister - Google Patents
Indol-3-karbonyl-spiro-piperidinderivater som V1A-reseptorantagonisterInfo
- Publication number
- NO20080059L NO20080059L NO20080059A NO20080059A NO20080059L NO 20080059 L NO20080059 L NO 20080059L NO 20080059 A NO20080059 A NO 20080059A NO 20080059 A NO20080059 A NO 20080059A NO 20080059 L NO20080059 L NO 20080059L
- Authority
- NO
- Norway
- Prior art keywords
- spiro
- carbonyl
- receptor antagonists
- piperidine derivatives
- indole
- Prior art date
Links
- 239000002464 receptor antagonist Substances 0.000 title abstract 2
- 229940044551 receptor antagonist Drugs 0.000 title abstract 2
- JUXAVSAMVBLDKO-UHFFFAOYSA-N 1-(1-azabicyclo[2.2.2]octan-3-yl)-3-[3-(1h-indol-3-yl)-1-oxo-1-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylpropan-2-yl]urea Chemical group C1N(CC2)CCC2C1NC(=O)NC(C(=O)N1CCC2(C3=CC=CC=C3CC2)CC1)CC1=CNC2=CC=CC=C12 JUXAVSAMVBLDKO-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010007558 Cardiac failure chronic Diseases 0.000 abstract 1
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010029164 Nephrotic syndrome Diseases 0.000 abstract 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 abstract 1
- 102000002852 Vasopressins Human genes 0.000 abstract 1
- 108010004977 Vasopressins Proteins 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 abstract 1
- 208000019425 cirrhosis of liver Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 229960003726 vasopressin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pregnancy & Childbirth (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05106443 | 2005-07-14 | ||
| EP05109364 | 2005-10-07 | ||
| PCT/EP2006/063846 WO2007006688A1 (en) | 2005-07-14 | 2006-07-04 | Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080059L true NO20080059L (no) | 2008-04-02 |
Family
ID=37001896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080059A NO20080059L (no) | 2005-07-14 | 2008-01-04 | Indol-3-karbonyl-spiro-piperidinderivater som V1A-reseptorantagonister |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US7332501B2 (de) |
| EP (1) | EP1904477B1 (de) |
| JP (1) | JP4927079B2 (de) |
| KR (1) | KR100974967B1 (de) |
| CN (1) | CN101253164B (de) |
| AR (1) | AR054830A1 (de) |
| AT (1) | ATE421511T1 (de) |
| AU (1) | AU2006268724B2 (de) |
| BR (1) | BRPI0612988A2 (de) |
| CA (1) | CA2615726C (de) |
| CY (1) | CY1108996T1 (de) |
| DE (1) | DE602006004997D1 (de) |
| DK (1) | DK1904477T3 (de) |
| ES (1) | ES2317558T3 (de) |
| HK (1) | HK1123554A1 (de) |
| IL (1) | IL188478A (de) |
| MX (1) | MX2008000585A (de) |
| MY (1) | MY144684A (de) |
| NO (1) | NO20080059L (de) |
| PL (1) | PL1904477T3 (de) |
| PT (1) | PT1904477E (de) |
| RU (1) | RU2414466C2 (de) |
| SI (1) | SI1904477T1 (de) |
| TW (1) | TWI312780B (de) |
| WO (1) | WO2007006688A1 (de) |
| ZA (1) | ZA200800320B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0612988A2 (pt) * | 2005-07-14 | 2010-12-14 | Hoffmann La Roche | derivados de indol-3-il-carbonil-espiro-piperidina como antagonistas de receptor v1a |
| CA2623715A1 (en) * | 2005-09-28 | 2007-04-12 | F. Hoffmann-La Roche Ag | Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| US7351706B2 (en) * | 2006-01-05 | 2008-04-01 | Hoffmann-La Roche Inc. | Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| CN101547923A (zh) * | 2006-12-07 | 2009-09-30 | 弗·哈夫曼-拉罗切有限公司 | 作为via受体拮抗剂的螺环-哌啶衍生物 |
| ES2345132T3 (es) | 2006-12-08 | 2010-09-15 | F. Hoffmann-La Roche Ag | Indoles que actuan como agonistas del receptor v1a. |
| WO2008077810A2 (en) * | 2006-12-22 | 2008-07-03 | F. Hoffmann-La Roche Ag | Spiro-piperidine derivatives |
| ATE536356T1 (de) | 2007-01-12 | 2011-12-15 | Hoffmann La Roche | Spiropiperidin-glycinamid-derivate |
| TW200940547A (en) * | 2007-12-13 | 2009-10-01 | Speedel Experimenta Ag | Organic compounds |
| WO2011137024A1 (en) * | 2010-04-26 | 2011-11-03 | Merck Sharp & Dohme Corp. | Novel spiropiperidine prolylcarboxypeptidase inhibitors |
| SI2683723T1 (sl) | 2011-03-10 | 2016-07-29 | Zoetis Services Llc | Spirociklični izoksazolinski derivati kot antiparazitiki |
| RU2475489C1 (ru) * | 2011-10-07 | 2013-02-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Чувашский государственный университет имени И.Н. Ульянова" | Способ получения 8-амино-1-имино-6-морфолин-4-ил-2-окса-7-азаспиро[4,4]нона-3,6,8-триен-9-карбонитрилов |
| SI2825542T1 (sl) | 2012-03-16 | 2017-01-31 | Vitae Pharmaceutical Inc., | Modulatorji jetrnega receptorja X |
| PL2825541T3 (pl) | 2012-03-16 | 2016-12-30 | Modulatory receptora x wątroby | |
| JO3109B1 (ar) * | 2012-05-10 | 2017-09-20 | Ferring Bv | منبهات لمستقبلات v1a |
| KR101698124B1 (ko) * | 2015-05-29 | 2017-01-19 | 한국외국어대학교 연구산학협력단 | 3-(메틸아미노)-3-((r)-피롤리딘-3-일)프로판니트릴 또는 이의 염의 제조방법 |
| WO2017137334A1 (en) * | 2016-02-08 | 2017-08-17 | F. Hoffmann-La Roche Ag | Spiroindolinones as ddr1 inhibitors |
| US20180002344A1 (en) | 2016-06-16 | 2018-01-04 | Genentech, Inc. | Heteroaryl estrogen receptor modulators and uses thereof |
| RU2752088C1 (ru) * | 2016-09-21 | 2021-07-22 | Вектус Байосистемс Лимитед | Композиции для лечения гипертензии и/или фиброза |
| TW201938171A (zh) | 2017-12-15 | 2019-10-01 | 匈牙利商羅特格登公司 | 作為血管升壓素Ｖ１ａ受體拮抗劑之三環化合物 |
| HU231206B1 (hu) | 2017-12-15 | 2021-10-28 | Richter Gedeon Nyrt. | Triazolobenzazepinek |
| CN113563255B (zh) * | 2020-04-29 | 2023-08-18 | 成都倍特药业股份有限公司 | 瑞芬沙星中间体的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686624A (en) * | 1992-01-30 | 1997-11-11 | Sanofi | 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| EP1410437A2 (de) * | 2001-01-22 | 2004-04-21 | Morgan Chemical Products, Inc. | Cvd-diamant verbessertes mikroprozessor-kühlsystem |
| BRPI0612988A2 (pt) * | 2005-07-14 | 2010-12-14 | Hoffmann La Roche | derivados de indol-3-il-carbonil-espiro-piperidina como antagonistas de receptor v1a |
-
2006
- 2006-07-04 BR BRPI0612988-9A patent/BRPI0612988A2/pt not_active IP Right Cessation
- 2006-07-04 AT AT06764048T patent/ATE421511T1/de active
- 2006-07-04 WO PCT/EP2006/063846 patent/WO2007006688A1/en active Application Filing
- 2006-07-04 EP EP06764048A patent/EP1904477B1/de not_active Not-in-force
- 2006-07-04 DK DK06764048T patent/DK1904477T3/da active
- 2006-07-04 MX MX2008000585A patent/MX2008000585A/es active IP Right Grant
- 2006-07-04 RU RU2008100082/04A patent/RU2414466C2/ru not_active IP Right Cessation
- 2006-07-04 KR KR1020087002692A patent/KR100974967B1/ko not_active IP Right Cessation
- 2006-07-04 SI SI200630231T patent/SI1904477T1/sl unknown
- 2006-07-04 PL PL06764048T patent/PL1904477T3/pl unknown
- 2006-07-04 AU AU2006268724A patent/AU2006268724B2/en not_active Ceased
- 2006-07-04 CN CN2006800321491A patent/CN101253164B/zh not_active Expired - Fee Related
- 2006-07-04 ES ES06764048T patent/ES2317558T3/es active Active
- 2006-07-04 PT PT06764048T patent/PT1904477E/pt unknown
- 2006-07-04 JP JP2008520842A patent/JP4927079B2/ja not_active Expired - Fee Related
- 2006-07-04 CA CA2615726A patent/CA2615726C/en not_active Expired - Fee Related
- 2006-07-04 DE DE602006004997T patent/DE602006004997D1/de active Active
- 2006-07-10 US US11/483,462 patent/US7332501B2/en not_active Expired - Fee Related
- 2006-07-10 TW TW095125012A patent/TWI312780B/zh not_active IP Right Cessation
- 2006-07-11 MY MYPI20063280A patent/MY144684A/en unknown
- 2006-07-12 AR ARP060102988A patent/AR054830A1/es not_active Application Discontinuation
-
2007
- 2007-12-27 IL IL188478A patent/IL188478A/en not_active IP Right Cessation
-
2008
- 2008-01-04 NO NO20080059A patent/NO20080059L/no not_active Application Discontinuation
- 2008-01-10 ZA ZA200800320A patent/ZA200800320B/xx unknown
- 2008-01-24 US US12/018,823 patent/US7629353B2/en not_active Expired - Fee Related
-
2009
- 2009-02-11 HK HK09101245.2A patent/HK1123554A1/xx not_active IP Right Cessation
- 2009-04-14 CY CY20091100447T patent/CY1108996T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20080059L (no) | Indol-3-karbonyl-spiro-piperidinderivater som V1A-reseptorantagonister | |
| NO20082733L (no) | Indol-3-yl-karbonyl-spiro-piperidinderivater | |
| WO2007014851A3 (en) | Indol-3-yl-carbonyl-piperidin and piperazin derivatives | |
| NO20080291L (no) | Indol-3-yl-karbonyl-piperidin-benzomidazolderivater som Via reseptorantagonister | |
| NO20071660L (no) | Nye pyridinonderivater og deres anvendelse som positive allosteriske modulatorer av MGLUR2-reseptorer | |
| NO20064579L (no) | Bifenylforbindelser anvendelige som muskariniske receptorantagonister | |
| WO2006021213A3 (en) | Vasopressin v1a antagonists | |
| WO2010036613A8 (en) | Novel cyclic benzimidazole derivatives useful anti-diabetic agents | |
| NO20083500L (no) | 1,4-disubstituerte 3-cyano-pyridonderivater og deres anvendelse som positiv-allosteriske modulatorer av mGluR2 receptorer | |
| NO20092762L (no) | 2-aza-bicyklo[3.1.0]heksanderivater | |
| NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
| EP2548568A3 (de) | Melanocortinrezeptorliganden | |
| NO20073019L (no) | Pyrasolonforbindelser som metabotrope glutamatreseptor-antagonister for behandlingen av nevrotiske og psykiatriske lidelser | |
| WO2007115077A3 (en) | Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators | |
| WO2008070462A3 (en) | N-oxides of 4,5-epoxy-morphinanium analogs | |
| CY1108880T1 (el) | Παραγωγα καρβοξαμιδιου ως ανταγωνιστες μουσκαρινικου υποδοχεα | |
| NO20051626L (no) | Azw-bicykloalkyletere og deres anvendelse som alfa-7-nAChR agonister | |
| NO20073876L (no) | Pyrazolopyrimidinderivater som mGluR2-antagonister | |
| WO2007020213A3 (en) | Thiazolyl piperidine derivatives useful as h3 receptor modulators | |
| NO20076060L (no) | Piperidin-4-yl-amidderivater og deres anvendelse som SST-reseptor subtype 5-antagonister | |
| WO2007127297A3 (en) | Crystalline forms of a dimethylphenyl compound | |
| WO2009024989A3 (en) | A novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form b | |
| WO2008099072A3 (fr) | Nouveaux derives de 2, 4-dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk | |
| WO2007067875A3 (en) | Pyridinyl sulfonamide modulators of chemokine receptors | |
| WO2006131338A3 (en) | Crystalline solvate of omeprazole sodium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |